Article
Targeted next-generation sequencing improves diagnosis of hereditary spastic paraplegia in Chinese patients.
Journal of molecular medicine (Berlin, Germany) - 1 Jul 2018
Lu Cong, Li Li-Xi, Dong Hai-Lin, Wei Qiao, Liu Zhi-Jun, Ni Wang, Gitler Aaron D, Wu Zhi-Ying
Abstract excerpt
Hereditary spastic paraplegia (HSP) is a heterogeneous group of neurodegenerative diseases characterized by progressive weakness and spasticity of lower limbs. To clarify the genetic spectrum and improve the diagnosis of HSP patients, targeted next-generation sequencing (NGS) was applied to detect the culprit genes in 55 Chinese HSP pedigrees. The classification of novel variants was based on the American College...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
